{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:06:30Z","timestamp":1776081990059,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1996,7,1]],"date-time":"1996-07-01T00:00:00Z","timestamp":836179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[1996,7]]},"DOI":"10.1007\/bf00052671","type":"journal-article","created":{"date-parts":[[2004,10,30]],"date-time":"2004-10-30T19:37:13Z","timestamp":1099165033000},"page":"449-457","source":"Crossref","is-referenced-by-count":125,"title":["Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States"],"prefix":"10.1007","volume":"7","author":[{"given":"Dawn B.","family":"Willis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia E.","family":"Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi L.","family":"Miracle-McMahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Clark W.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00052671_CR1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","volume":"117","author":"D Grady","year":"1992","unstructured":"Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med 1992; 117: 1016\u201337.","journal-title":"Ann Intern Med"},{"key":"BF00052671_CR2","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-0528.1990.tb02494.x","volume":"97","author":"K Hunt","year":"1990","unstructured":"Hunt K, Vessey M, McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 1990; 97: 1080\u20136.","journal-title":"Br J Obstet Gynaecol"},{"key":"BF00052671_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","volume":"151","author":"BE Henderson","year":"1991","unstructured":"Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991; 151: 75\u20138.","journal-title":"Arch Intern Med"},{"key":"BF00052671_CR4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jnci\/87.7.517","volume":"87","author":"EE Calle","year":"1995","unstructured":"Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. JNCI 1995; 87: 517\u201323.","journal-title":"JNCI"},{"key":"BF00052671_CR5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jnci\/87.14.1067","volume":"87","author":"PA Newcomb","year":"1995","unstructured":"Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large bowel cancer. JNCI 1995; 87: 1067\u201371.","journal-title":"JNCI"},{"key":"BF00052671_CR6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/oxfordjournals.aje.a117244","volume":"140","author":"A Paganini-Hill","year":"1994","unstructured":"Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994; 140: 256\u201361.","journal-title":"Am J Epidemiol"},{"key":"BF00052671_CR7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0140-6736(91)90417-N","volume":"338","author":"LF Voight","year":"1991","unstructured":"Voight LF, Weiss NS, Chu J, Daling JR, McKnight B, vanBelle G. Progestogen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991; 338: 274\u20137.","journal-title":"Lancet"},{"key":"BF00052671_CR8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0029-7844(94)00339-F","volume":"85","author":"DK Wysowski","year":"1995","unstructured":"Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States 1982\u20131992. Obstet Gynecol 1995; 85: 6\u201310.","journal-title":"Obstet Gynecol"},{"key":"BF00052671_CR9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/1097-0142(19940801)74:3+<1111::AID-CNCR2820741520>3.0.CO;2-L","volume":"74","author":"BS Hulka","year":"1994","unstructured":"Hulka BS, Liu ET, Lininger RA. Steroid hormones and risk of breast cancer. Cancer Sup 1994; 74: 1111\u201324.","journal-title":"Cancer Sup"},{"key":"BF00052671_CR10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/oxfordjournals.epirev.a036117","volume":"15","author":"LA Brinton","year":"1993","unstructured":"Brinton LA, Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev 1993; 15: 66\u201379.","journal-title":"Epidemiol Rev"},{"key":"BF00052671_CR11","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.1992.03490140108044","volume":"268","author":"JB Henrich","year":"1992","unstructured":"Henrich JB. The postmenopausal estrogen\/breast cancer controversy. JAMA 1992; 268: 1900\u20132.","journal-title":"JAMA"},{"key":"BF00052671_CR12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/1097-0142(19890801)64:3<591::AID-CNCR2820640305>3.0.CO;2-U","volume":"64","author":"PK Mills","year":"1989","unstructured":"Mills PK, Beeson LW, Phillips RL, Fraser GE. Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists. Cancer 1989; 64: 591\u20137.","journal-title":"Cancer"},{"key":"BF00052671_CR13","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","volume":"332","author":"GA Colditz","year":"1995","unstructured":"Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589\u201393.","journal-title":"N Engl J Med"},{"key":"BF00052671_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.1995.03530020055032","volume":"274","author":"JL Stanford","year":"1995","unstructured":"Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274: 137\u201342.","journal-title":"JAMA"},{"key":"BF00052671_CR15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0002-9378(11)90784-4","volume":"168","author":"GA Colditz","year":"1993","unstructured":"Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 1993; 168: 1473\u201380.","journal-title":"Am J Obstet Gynecol"},{"key":"BF00052671_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00001648-199407000-00007","volume":"5","author":"KK Steinberg","year":"1994","unstructured":"Steinberg KK, Smith SJ, Thacker SB, Stroup DF. Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology 1994; 5: 415\u201321.","journal-title":"Epidemiology"},{"key":"BF00052671_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF01831376","volume":"5","author":"C Schairer","year":"1994","unstructured":"Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR, Hoover RN. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control 1994; 5: 491\u2013500.","journal-title":"Cancer Causes Control"},{"key":"BF00052671_CR18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","volume":"321","author":"L Bergkvist","year":"1989","unstructured":"Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogenprogestin replacement. N Engl J Med 1989; 321: 293\u20137.","journal-title":"N Engl J Med"},{"key":"BF00052671_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJM197608192950801","volume":"295","author":"RN Hoover","year":"1976","unstructured":"Hoover RN, Gray LA, Cole P, MacMahon B. Menopausal estrogens and breast cancer. N Engl J Med 1976; 295: 401\u20135.","journal-title":"N Engl J Med"},{"key":"BF00052671_CR20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/oxfordjournals.aje.a116041","volume":"134","author":"DW Kaufman","year":"1991","unstructured":"Kaufman DW, Palmer JR, deMouzon J, et al. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. Am J Epidemiol 1991; 134: 1375\u201385.","journal-title":"Am J Epidemiol"},{"key":"BF00052671_CR21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00051356","volume":"3","author":"GA Colditz","year":"1992","unstructured":"Colditz GA, Stampfer MJ, Willett WC, Hunter DJ, Manson JE, Hennekens CH. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control 1992; 3: 423\u20139.","journal-title":"Cancer Causes Control"},{"key":"BF00052671_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00001648-199505000-00006","volume":"6","author":"SR Sturgeon","year":"1995","unstructured":"Sturgeon SR, Schairer C, Brinton LA, Pearson T, Hoover RN. Evidence of a healthy estrogen user survivor effect. Epidemiology 1995; 6: 227\u201330.","journal-title":"Epidemiology"},{"key":"BF00052671_CR23","first-page":"400","volume":"80","author":"DM Strickland","year":"1992","unstructured":"Strickland DM, Gambrell RD, Butzin CA, Strickland K. The relationship between breast cancer survival and prior postmenopausal estrogen use. Obstet Gynecol 1992; 80: 400\u20134.","journal-title":"Obstet Gynecol"},{"key":"BF00052671_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/oxfordjournals.aje.a116664","volume":"137","author":"EE Calle","year":"1993","unstructured":"Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993; 137: 235\u201341.","journal-title":"Am J Epidemiol"},{"key":"BF00052671_CR25","volume-title":"International Classification of Diseases, Ninth Revision","author":"World Health Organization","year":"1977","unstructured":"World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1977."},{"key":"BF00052671_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187\u2013220.","journal-title":"J R Stat Soc (B)"},{"key":"BF00052671_CR27","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ijc.2910430606","volume":"43","author":"DA Leon","year":"1989","unstructured":"Leon DA. A prospective study of the independent effects of parity and age at first birth on breast cancer incidence in England and Wales. Int J Cancer 1989; 43: 986\u201391.","journal-title":"Int J Cancer"},{"key":"BF00052671_CR28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/oxfordjournals.epirev.a036056","volume":"12","author":"JL Kelsey","year":"1990","unstructured":"Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev 1990; 12: 228\u201340.","journal-title":"Epidemiol Rev"},{"key":"BF00052671_CR29","volume-title":"Epidemiologic Research: Principles and Quantitative Methods","author":"DG Kleinbaum","year":"1982","unstructured":"Kleinbaum DG, Kupper LL, Morgenstern H, Epidemiologic Research: Principles and Quantitative Methods. New York, NY (USA): Van Nostrand Reinhold Co. 1982."},{"key":"BF00052671_CR30","first-page":"690","volume":"56","author":"N Mantel","year":"1983","unstructured":"Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1983; 56: 690\u2013700.","journal-title":"J Am Stat Assoc"},{"key":"BF00052671_CR31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/1097-0142(195609\/10)9:5<927::AID-CNCR2820090510>3.0.CO;2-3","volume":"9","author":"AM Lilienfeld","year":"1956","unstructured":"Lilienfeld AM. The relationship of cancer of the female breast to artificial menopause and marital status. Cancer 1956; 9: 927\u20139.","journal-title":"Cancer"},{"key":"BF00052671_CR32","first-page":"605","volume":"48","author":"D Trichopoulos","year":"1972","unstructured":"Trichopoulos D, MacMahon B, Cole P. The menopause and breast cancer risk. JNCI 1972; 48: 605\u201313.","journal-title":"JNCI"},{"key":"BF00052671_CR33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.epirev.a036116","volume":"15","author":"L Bernstein","year":"1993","unstructured":"Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993; 15: 48\u201365.","journal-title":"Epidemiol Rev"},{"key":"BF00052671_CR34","first-page":"319","volume":"4","author":"JD Potter","year":"1995","unstructured":"Potter JD, Cerhan JR, Sellers TA, et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomark Prev 1995; 4: 319\u201326.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"BF00052671_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/oxfordjournals.aje.a115328","volume":"130","author":"L Bergkvist","year":"1989","unstructured":"Bergkvist L, Adami HO, Persson I, Bergstrom R, Kruseno UB. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 1989; 130: 221\u20138.","journal-title":"Am J Epidemiol"},{"key":"BF00052671_CR36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00051340","volume":"4","author":"I Yuen","year":"1993","unstructured":"Yuen I, Persson I, Bergkvist L, Hoover R, Schairer C, Adami HO. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for \u2018healthy drug-user\u2019 effect. Cancer Causes Control 1993; 4: 369\u201374.","journal-title":"Cancer Causes Control"},{"key":"BF00052671_CR37","unstructured":"Matthews KA, Bromberger J, Egeland G. Behavioral antecedents and consequences of the menopause. In: Korenman SG, ed. The Menopause: Biological and Clinical Consequences of Ovarian Failure: Evolution and Management. Nada, CA (USA): Serono Symposia 1989; 1\u201310."},{"key":"BF00052671_CR38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bjc.1986.246","volume":"54","author":"LA Brinton","year":"1986","unstructured":"Brinton LA, Hoover R, Fraumeni JFJr. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer 1986; 54: 825\u201332.","journal-title":"Br J Cancer"},{"key":"BF00052671_CR39","first-page":"167","volume":"178","author":"R Squitieri","year":"1994","unstructured":"Squitieri R, Tartter PI, Ahmed S, Brower ST, Theise ND. Carcinoma of the breast in postmenopausal hormone user and nonuser control groups. J Am Coll Surg 1994; 178: 167\u201370.","journal-title":"J Am Coll Surg"},{"key":"BF00052671_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0029-7844(94)00324-7","volume":"85","author":"P Bonnier","year":"1995","unstructured":"Bonnier P, Romain S, Giacalone PL, Laffargue F, Martin PM, Peana L. Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 1995; 85: 11\u20137.","journal-title":"Obstet Gynecol"},{"key":"BF00052671_CR41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/oxfordjournals.aje.a114722","volume":"126","author":"JA Schwartzbaum","year":"1987","unstructured":"Schwartzbaum JA, Hulka BS, Fowler WC, Kaufman DG, Hoberman D. The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer. Am J Epidemiol 1987; 126: 851\u201360.","journal-title":"Am J Epidemiol"},{"key":"BF00052671_CR42","first-page":"229","volume":"49","author":"HCJ Nyholm","year":"1993","unstructured":"Nyholm HCJ, Nielsen AL, Norup P. Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: comparison of clinical and histopathological characteristics. Oncology 1993; 49: 229\u201335.","journal-title":"Oncology"},{"key":"BF00052671_CR43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ijc.2910490409","volume":"49","author":"M Ewertz","year":"1991","unstructured":"Ewertz M, Gillanders S, Meyer L, Zedela K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 1991; 49: 526\u201330.","journal-title":"Int J Cancer"},{"key":"BF00052671_CR44","volume-title":"National Health Survey","author":"US Department Health and Human Services","year":"1990","unstructured":"US Department Health and Human Services. National Health Survey. Washington DC: National Center for Health Statistics, 1990; Series 10 (181: Table 58)."},{"key":"BF00052671_CR45","first-page":"161","volume":"83","author":"RD Gorsky","year":"1994","unstructured":"Gorsky RD, Koplan JP, Peterson HB, Thaeker SB. Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis. Obstet Gynecol 1994; 83: 161\u20136.","journal-title":"Obstet Gynecol"},{"key":"BF00052671_CR46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.1991.03470040130037","volume":"266","author":"B Healy","year":"1991","unstructured":"Healy B. Women's health, public welfare. JAMA 1991; 266: 566\u20138.","journal-title":"JAMA"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00052671.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00052671\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00052671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00052671.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:56:55Z","timestamp":1734598615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00052671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,7]]}},"alternative-id":["BF00052671"],"URL":"https:\/\/doi.org\/10.1007\/bf00052671","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,7]]}}}